1. Market Research
  2. > Healthcare Market Trends
  3. > Diagnostics

Medical Diagnostics Industry Overview: Latest Market Reports & Studies

  • Currently 4/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
13 votes

Global Diagnostics Industry

The diagnostics industry involves testing patients to detect disease. Diagnosis can be used in the case of patients already presenting symptoms of disease, to screen asymptomatic patients as a matter of routine, and to allow ongoing testing in patients with disease to establish prognosis or check progress of therapy. The section is part of the wider healthcare industry.

The market can be broadly divided into:

  1. In vitro diagnostics (IVD), which refers to testing samples of blood, tissue, for example electrocardiography; and
  2. Diagnostic imaging, such as x-rays, computerized axial tomography (CAT), mammograms and magnetic resonance imaging (MRI).

Leading Market Segment

The IVD market, estimated at $44 billion in 2010, is predicted to reach $52 billion by 2013 with a compound annual grown rate of approximately 5%, according to research from RNCOS. A particularly profitable growth sector within IVD, molecular diagnostics is predicted to reach $15 billion by 2014 at a compound annual growth rate of just under 20% reports Renub Research. Infectious diseases account for more than a fifth of this segment, followed by oncology testing. By 2014 blood testing and genetic screening together will account for over a quarter of the market, with the US representing $6 billion of the molecular diagnostics market by that time.

Blood grouping reagent Export

Diagnostics Industry Regional Market Share

The In Vitro Diagnostic market is dominated by the US and the EU, which combined comprise about three quarters of the global market. This is because developed countries are witnessing a proliferation of diet and lifestyle related diseases such as cancer, diabetes and cardiovascular disease, whereas developing countries are more concerned with the diagnosis of infection and infectious disease.

In the lead, the IVD market in the US is forecast to grow 5.4% annually, reaching $23 billion in 2013. According to Global Industry Analysts, the US molecular diagnostics market will be over $6.35 billion by 2015.

Following behind, the EU represents the second-largest regional market, with its infectious-disease testing market estimated to reach $1.02 billion in 2012. There is strong growth in oncology testing and pharmacogenomics, which are predicted to show a compound annual growth rate of 10.71% and 11.05%, respectively, between 2011 and 2015.

Top 3 Medical Diagnostics Players

Roche is the market leader in IVD, holding approximately 20% of total market share, followed by Abbott and Siemens, each holding more than 10%.

Roche’s 20% market share represents yearly sales of $44 billion, with key products such as CoaguChek and Accu-Chek fueling the company’s growth. Roche saw 20% growth in Asia-Pacific alone and a 5% rise in the US. Acquisitions, such as in diabetes care (Medingo Ltd) and tissue diagnostics (Biolmagene Inc), should see continued market growth for Roche going forward.

In business for over 120 years, Abbott's sales in 2010 reached over $35 billion, and it invested $3.7 billion in R&D. Its main area of expertise in diagnostics is immunodiagnostics. Abbott's immunoassay diagnostic systems, AxSYM, is used to test for cardiovascular disease, cancer, infectious diseases and thyroid conditions.

Read more »

Share
24/7 Customer Support

Talk to Sam

+1 718 473 0872

1-10 of about 300 reports

Global Diagnostics Industry - Forecast

  • May 2016
    23 pages
  • Diagnostics  

    Biomarker  

  • World  

    Europe  

View report >

Diagnostics Markets in the US

  • April 2016
    18 pages
  • United States  

View report >

Diagnostics Forecast Statistics in Europe

  • February 2015
    96 pages
  • Europe  

    World  

View report >

Diagnostics Industry in Canada

  • January 2017
    11 pages
  • Canada  

View report >

The future of the Clinical Trial Industry in the US

  • January 2017
    2 pages
  • Clinical Trial  

    Genome Sequenci...  

    Biopsy  

  • United States  

View report >

Diagnostics Market Forecast in the US

  • January 2017
  • Diagnostics  

  • United States  

View report >

Diagnostics Market Forecast in the US

  • January 2017
  • Diagnostics  

  • United States  

View report >

Diagnostics Market Forecast in the US

  • January 2017
  • Diagnostics  

  • United States  

View report >

The future of the Diagnostics Industry

  • January 2017
    2 pages
  • Diagnostics  

View report >

Breast Cancer Statistics - Forecast

  • December 2016
    2 pages
  • Breast Cancer  

    Biopsy  

View report >


About 3200 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 87 - $ 36000)

2017 Europe Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 Europe Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 36000
  • Industry report
  • February 2017
  • by Venture Planning Group

This new 31-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as ...

Cancer Diagnostics 2017-2021: Us, Europe, Japan--market ...

December 2016 $ 21100

2017 Asia-pacific Infectious Disease Testing Market: Sa ...

January 2017 $ 13700

2017 Asia-pacific Virology And Bacteriology Testing Mar ...

January 2017 $ 13700

Europe Microbiology Market 2017-2021: France, Germany, ...

December 2016 $ 12900

2017 Asia-pacific Cancer Diagnostics Market: Sales Fore ...

February 2017 $ 11300

2017 Asia-pacific Tumor Marker Diagnostics Market: Sale ...

February 2017 $ 11300

2017-2021 World Sexually-transmitted Disease (std) Diag ...

January 2017 $ 9600

2017 Middle East Cancer Diagnostics Market: Sales Forec ...

February 2017 $ 8250

2017 Middle East Tumor Marker Diagnostics Market: Sales ...

February 2017 $ 8250

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.